Navamedic ASA

OL:NAVA Norway Medical Distribution
Market Cap
$43.15 Million
Nkr491.62 Million NOK
Market Cap Rank
#23893 Global
#127 in Norway
Share Price
Nkr20.50
Change (1 day)
-1.91%
52-Week Range
Nkr18.15 - Nkr26.40
All Time High
Nkr42.60
About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more

Navamedic ASA (NAVA) - Total Liabilities

Latest total liabilities as of September 2025: Nkr503.20 Million NOK

Based on the latest financial reports, Navamedic ASA (NAVA) has total liabilities worth Nkr503.20 Million NOK as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Navamedic ASA - Total Liabilities Trend (2003–2024)

This chart illustrates how Navamedic ASA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Navamedic ASA Competitors by Total Liabilities

The table below lists competitors of Navamedic ASA ranked by their total liabilities.

Company Country Total Liabilities
ProMIS Neurosciences Inc.
NASDAQ:PMN
USA $12.27 Million
Lien Chang Electronic Enterprise Co Ltd
TW:2431
Taiwan NT$171.19 Million
Spir Group ASA
OL:SPIR
Norway Nkr645.14 Million
Walkabout Resources Ltd
AU:WKT
Australia AU$36.64 Million
Samaiden Group Bhd
KLSE:0223
Malaysia RM364.08 Million
Inversiones Doalca SOCIMI SA
MC:YDOA
Spain €7.91 Million
Paratech Company Limited
KQ:033540
Korea ₩110.79 Billion

Liability Composition Analysis (2003–2024)

This chart breaks down Navamedic ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.32 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.40 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.71 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Navamedic ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Navamedic ASA (2003–2024)

The table below shows the annual total liabilities of Navamedic ASA from 2003 to 2024.

Year Total Liabilities Change
2024-12-31 Nkr250.81 Million -16.93%
2023-12-31 Nkr301.91 Million +74.46%
2022-12-31 Nkr173.05 Million -3.29%
2021-12-31 Nkr178.94 Million +37.07%
2020-12-31 Nkr130.55 Million +21.08%
2019-12-31 Nkr107.83 Million -6.57%
2018-12-31 Nkr115.41 Million -23.35%
2017-12-31 Nkr150.57 Million -17.24%
2016-12-31 Nkr181.94 Million +15.68%
2015-12-31 Nkr157.27 Million +54.23%
2014-12-31 Nkr101.97 Million +41.19%
2013-12-31 Nkr72.22 Million +94.80%
2012-12-31 Nkr37.07 Million -19.11%
2011-12-31 Nkr45.83 Million +98.24%
2010-12-31 Nkr23.12 Million -6.65%
2009-12-31 Nkr24.77 Million -49.86%
2008-12-31 Nkr49.40 Million -12.51%
2007-12-31 Nkr56.46 Million -768.93%
2006-12-31 Nkr-8.44 Million -275.64%
2005-12-31 Nkr4.81 Million -347.21%
2004-12-31 Nkr-1.94 Million -69.81%
2003-12-31 Nkr-6.44 Million --